ME
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.936
Exchange
XSWX - Six Swiss Exchange
2 %
Last period ROE
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Medartis
Company Analysis
MED.SW valuation, rating, competitors, insights and company profile
Eyestock Rating
MED.SW financial analysis by Eyestock methodology
Valuation
MED.SW valuation using historical relative method
Statements
MED.SW Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MED.SW dividend yield and annual dividend
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
Medartis`s ROE for the last twelve months ended 2024-06-30 is 2 %
